Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DuPont Pharma Has "A Number Of Bidders"; Company Still Considering IPO

Executive Summary

DuPont has had several companies express interest in purchasing its pharmaceutical business, DuPont Pharmaceuticals Chairman Richard DeSchutter told an April 11 meeting with securities analysts.

You may also be interested in...



DuPont Oral TNF Inhibitor For Arthritis, Sustiva Successor Are In Phase II

DuPont Pharmaceuticals expects to file an NDA for an orally dosed TNF inhibitor in 2004, the company told analysts April 11.

DuPont Oral TNF Inhibitor For Arthritis, Sustiva Successor Are In Phase II

DuPont Pharmaceuticals expects to file an NDA for an orally dosed TNF inhibitor in 2004, the company told analysts April 11.

DuPont Spinning Off Rx Business As Cozaar Profit-Share Trigger Nears

DuPont's handling of the profit-sharing agreement for Cozaar is a central consideration in the valuing of the company's planned prescription drug spin-off.

UsernamePublicRestriction

Register

LL111799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel